Skip Main Navigation | Skip to Content

Walsh selected to conduct HIV PrEP research

Bookmark and Share

June 29, 2017

Rising third-year med student Tim Walsh is one of 14 medical students nationwide chosen by the HIV Medicine Association to receive funding for HIV clinical learning and research. As a 2017 HIVMA Medical Student Program Award winner, Walsh will receive free membership to the HIVMA and the Infectious Disease Society of America, as well as a stipend of $3,500 per year for up to three years to support his research.

Walsh will work under the mentorship of Moira McNulty, M.D., a clinical instructor at the University of Chicago Pritzker School of Medicine, on his project “Goal-Setting in a Pre-exposure Prophylaxis (PrEP) Intervention Among Young Black Men Who Have Sex with Men.”

“In doing this research, these students are demonstrating a commitment to the spirit of inquiry that will be essential to continued advances in prevention, care, treatment and control of HIV, and to improving the lives of their patients,” HIVMA Chair Wendy Armstrong, M.D., said in a press release. “We look forward to the contributions they will make through this program and into the future.”

Walsh has received substantial support and recognition for his research on PrEP, an HIV-prevention medication taken once a day. After graduation from the University of Chicago, Walsh joined the Chicago Center for HIV Elimination in 2013. At the center, he designed and implemented a social network intervention called PrEP Chicago, in which he trained peer educators on PrEP.

In summer 2016, Walsh worked to increase awareness and use of the medication with the support of a $6,000 Alpha Omega Alpha Kukein Fellowship and $2,000 Infectious Disease Society of America Medical Scholars Program Fellowship.

He also earned recognition from the American Medical Association after he presented his research findings at the 2016 AMA Research Symposium in Orlando. He finished first in the category for public health and epidemiology.